Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0035078 (
renal failure
)
31,970
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
From 1972 to 1986, 22 patients underwent surgical treatment for severe renovascular hypertension and rapidly progressive
renal failure
caused by atherosclerotic disease of the renal artery or dysplasia (group A), or by post-transplant
renal artery stenosis
(group B). 1. Group A (n = 16): These patients were assessed preoperatively with the measurement of serum creatinine and blood-urea levels (means 271 +/- 204 mumol/l and 15.6 +/- 10.3 mmol/l respectively) and renal clearances. 5 patients underwent aorto-renal bypass (bilateral in one case) and 11 patients were treated by autotransplantation of the kidney. Operative mortality was 6.2%. Improvement in renal function was statistically significant at 1 and 6 months postoperatively (p less than 0.05). After a mean follow-up of 31 +/- 12 months, renal function was normal in 8 patients, improved in 4, unchanged in 1 and worse in 2. At short and long-term, 81% of the patients were normotensive without medication of with an improved blood pressure (p less than 0.001). 2. Group B (n = 6): Transplant revascularisation was performed on average 10 +/- 8 months after renal transplantation. 5 patients had renal function impairment (mean serum creatinine 241 +/- 96 mumol/l, mean blood-urea 16 +/- 17 mumol/l) and 1 patient a posttransplant anuria. Resection of anastomotic (n = 2) or post-anastomotic (n = 4) lesions was carried out in all case with a new anastomosis (n = 2) or a "crossed" anastomosis (n = 4). On the 24th hour one patient underwent a second revascularization because of immediate postoperative anuria secondary to another anastomotic stenosis.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:[Renal failure caused by renal artery stenosis: effects of revascularization]. 332 96
As newer surgical techniques and concepts have emerged, including revascularization of the totally occluded renal artery and alternatives to aortorenal bypass (hepatic, splenic, or iliac artery to renal artery grafts), our patient population has changed. Patients with diffuse atherosclerotic disease, bilateral
renal artery stenosis
, totally occluded renal arteries, and azotemia are being referred for renal revascularization, thereby changing the indications for operation and the results that can be anticipated. Although our results in patients operated on solely for uncontrollable hypertension or
renal failure
have been successful, much work needs to be done to improve the results obtained when patients have a combination of uncontrollable hypertension and
renal failure
.
...
PMID:Changing concepts in surgical management of renovascular hypertension. 334 38
Non-steroidal anti-inflammatory drugs (NSAIDs) may produce acute renal failure, papillary necrosis and interstitial nephritis. These adverse drug reactions are rare but have been reported in patients with congestive heart failure, cirrhosis, renal parenchymal disease, lupus nephritis and hypertension. All these conditions may be associated with hypovolaemia and an activated renin-angiotensin system, when renal blood flow and glomerular filtration depend on local renal prostaglandin biosynthesis. A severe impairment of renal function may occur when this synthesis is inhibited by NSAID treatment. It is possible that 1 in 100 of elderly patients have renal parenchymal disease, 1 in 100 arteriolar nephrosclerosis, 1 in 200 unilateral or bilateral
renal artery stenosis
and an unknown number suffer from atheroembolic renal disease. Fortunately, only a small proportion of 'at risk' patients given NSAIDs appear to develop
renal failure
. Perhaps bilateral renal disease or salt depletion are necessary factors? Whatever the explanation, NSAIDs should be used with caution in the elderly.
...
PMID:Pharmaco-epidemiological considerations in patients with arthritis and vascular disease of the kidney. 349 36
From 1973 through 1984, graft replacement of infrarenal aortic aneurysms (N = 56) or occlusive disease (N = 33) was performed in conjunction with simultaneous renal revascularization in 89 patients. Isolated
renal artery stenosis
was corrected by unilateral reconstruction in 56 patients (63%), but the remaining 33 (37%) had diffuse involvement that required either bilateral renal artery grafts or unilateral revascularization of solitary kidneys. The incidence of hypertension (greater than 180/90 mm Hg) refractory to preoperative medical therapy (88%), severe coronary disease documented by angiography (40%), and postoperative azotemia (33%) or oliguric
renal failure
(15%) was significantly higher among patients with bilateral renal artery disease (p less than 0.05). In addition, this group had twice the early mortality rate (15%) of patients having unilateral renal artery lesions (7.1%). During a mean follow-up interval of 37 months, medical control of hypertension was enhanced in 46 of the 80 operative survivors (58%), and renal function improved or remained stable in 63 survivors (79%). Five-year actuarial survival presently is 65% for the entire series, with a cumulative mortality rate of 38% among patients who underwent aneurysm resection (mean age 64 years) in comparison to 15% (p = 0.03) for those patients with aortoiliac occlusive disease (mean age 60 years).
...
PMID:Simultaneous aortic reconstruction and renal revascularization: risk factors and late results in eighty-nine patients. 357 9
Captopril is a new orally active angiotensin converting enzyme inhibitor that is useful for the treatment of hypertension. Prior reports have cautioned against its use for the control of blood pressure in patients with transplant
renal artery stenosis
since it caused a reversible
renal failure
. We describe a four year old child with radiographically proven transplant
renal artery stenosis
and severe hypertension that was safely managed with long-term administration of captopril. This case highlights the continued therapeutic role of this drug in the treatment of post-transplant hypertension, provided one carefully monitors the renal function in such patients.
...
PMID:The use of captopril to control hypertension in post-transplant renal artery stenosis. 389 Nov 79
Acute reversible
renal failure
has been reported in patients receiving captopril, especially those with unilateral or bilateral
renal artery stenosis
. Two patients with advanced renal disease presented with an acute deterioration in renal function after the introduction of captopril treatment. In both instances this deterioration was irreversible. Captopril should be used with caution in patients with advanced renal disease.
...
PMID:Deterioration in renal function in patients with chronic renal failure after treatment with captopril. 390 97
Suppression of the renin-angiotensin system (RAS) by angiotensin converting enzyme (ACE) inhibition may induce
renal failure
in patients with bilateral
renal artery stenosis
. Recent scintigraphic studies with the glomerular tracer technetium-99m-diethylenetriaminepenta-acetate (99m-Tc DTPA) indicate that in patients with unilateral
renal artery stenosis
, glomerular filtration rate (GFR) may be markedly reduced in the affected kidney after inhibition of ACE. This finding reflects the important role of the RAS in maintaining GFR (by increasing postglomerular resistance) in states of low renal perfusion pressure. Preliminary observations suggest that this scintigraphic test might be useful in the detection of renovascular hypertension.
...
PMID:Kidney scintigraphy after ACE inhibition in the diagnosis of renovascular hypertension. 391 23
Pediatric
renal failure
patients can be restored to health with peritoneal dialysis more easily, more comfortably, and more safely than with hemodialysis. During the past 3.5 years, we have treated 22 children with either acute (less than 30 days) or chronic (greater than 30 days) peritoneal dialysis (PD) at Henrietta Egleston Hospital for Children. They ranged in age from 2 weeks to 15 1/6 years, mean 5.2 years. The indications for acute dialysis were
renal failure
following cardiac surgery (4); hemolytic-uremic syndrome (4); and
renal failure
associated with bromide intoxication (1), congenital urethral stricture (1), or bronchopulmonary dysplasia (1). Chronic dialysis was utilized for end-stage renal disease caused by glomerulonephritis (5), chronic infection (2), hemolytic-uremic syndrome (1), cystinosis (1), congenital
renal artery stenosis
(1), and unknown etiology (1). Thirty-four adult or pediatric Tenckhoff catheters were utilized to deliver PD for from 6 to 551 days (18 months). Pediatric Tenckhoff catheters must be pre-measured in order to have the Dacron cuffs glued to the appropriate position on the catheter (7-12 cm from the end) to fit the child. There were seven catheter-related infections in four patients; three required catheter revision and four were treated medically. There were eight catheter-related mechanical problems, all of which required re-operation. All of those on chronic PD and seven of those on acute PD survived for an overall survival of 82 per cent. All surviving patients have been restored to health either by recovery of renal function (6 patients), renal transplantation (8 patients), or maintenance of chronic ambulatory peritoneal dialysis (4 patients).
...
PMID:Peritoneal dialysis in infants and children. 394 37
The serum converting enzyme activity (SCEA) was measured in 86 healthy individuals (1.44 +/- 0.82 u, mean +/- SD), 39 patients with essential hypertension (1.53 +/- 0.71 u), 7 patients with hypertension due to
renal artery stenosis
(1.76 +/- 0.77 u), 14 patients with chronic renal failure (2.10 +/- 0.57 u), 7 patients with
renal failure
and hypertension (2.62 +/- 0.35 u), 22 normotensive pregnant women (1.02 +/- 0.26 u) and 6 hypertensive pregnant women (1.1 +/- 0.3). No difference was detected between men and women or between normotensives and hypertensives. However, a significant rise in SCEA was found in patients with chromic
renal failure
(P less than 0.005), in whom an enlarged pulmonary vascular bed and accelerated cellular breakdown are thought to be the causes of the elevated SCEA. During pregnancy, subnormal SCEA was found (P less than 0.005), and this is thought to be due to the enzyme consumption in the kinin system, which is activated during pregnancy. We assume that converting enzyme is not a limiting factor in angiotensin conversion, and most probably it does not contribute significantly to the pathogenesis of hypertension.
...
PMID:Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension. 609 66
We report on 21 severely hypertensive patients with
renal artery stenosis
and renal insufficiency in whom percutaneous transluminal angioplasty and/or renal artery surgery was done in an effort to lower blood pressure and to preserve renal function. Of 12 patients who underwent angioplasty renal function and blood pressure improved in 3. Of the 9 patients without improvement 4 suffered permanent oliguric
renal failure
. An operation was performed in 12 patients, 4 after having failed angioplasty (1 was treated at another institution before referral for surgery). Two patients died postoperatively but 10 improved, with followup in 6 exceeding 3 years. This retrospective experience suggests that percutaneous transluminal angioplasty is not likely to supplant an operation in the treatment of patients with atherosclerotic renovascular hypertension and renal insufficiency.
...
PMID:Intervention in patients with renovascular hypertension and renal insufficiency. 622 43
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>